Latest debt-to-equity ratio
Aardvark Therapeutics Debt-to-equity ratio
Direct answer
Aardvark Therapeutics's debt-to-equity ratio is 0.91%.
The verified market snapshot reports 0.91%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 6, 2026.
Get free Aardvark Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.91%
Explore related company data
View Aardvark Therapeutics's market capitalizationView Aardvark Therapeutics's price-to-book ratioView Aardvark Therapeutics's return on equityView Aardvark Therapeutics's dividend yieldView Aardvark Therapeutics's 52-week price rangeView Aardvark Therapeutics's profit marginView all Aardvark Therapeutics key metricsReturn to Aardvark Therapeutics profile